F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’
www.nytimes.com
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.

Dr. Marty Makary, the Food and Drug Administration commissioner, wrote an article in the journal JAMA arguing that A.I. would “radically increase efficiency” in the process of deciding whether to approve new drugs and devices.

From NYT > Top Stories via this RSS feed